CTRI/2020/04/024793
Not yet recruiting
Phase 2
Role of Dienogest in the treatment of endometriosis
KMC Manipal0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: N801- Endometriosis of ovary
- Sponsor
- KMC Manipal
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Ultrasonographic diagnosis of ovarian endometrioma with mean diameter of 40mm or less
- •2\.Atleast one symptoms like dysmenorrhea,chronic pelvic pain, dyspareuria should be present
Exclusion Criteria
- •1\.Patients planned for surgical management
- •2\. any harmonal therapy undertaken within three months before enrollment
- •3\. patients with suspected malignancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Treating Endometriosis: Pill of Dienogest alone vs. Pill of Dienogest with Hormonal Intrauterine Device - a randomized clinical trialRBR-68j3f26niversidade Estadual de Campinas
Unknown
Phase 4
Role of Dienogest in the Treatment of Patient With Symptomatic AdenomyosisAdenomyosisNCT03654144Assiut University100
Unknown
Phase 4
Effects of Dienogest and Dienogest Plus Estradiol Valerate in Ovarian EndometriomaOvarian ReserveNCT03789123Bagcilar Training and Research Hospital710
Completed
Not Applicable
A Study to Learn More About Using Dienogest to Treat Endometriosis in Chinese ParticipantsEndometriosisNCT04495855Bayer968
Unknown
Phase 2
Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With EndometriosisEndometriosisNCT04256200American University of Beirut Medical Center100